NewsBite

Thorney Opportunities Ltd

ASX Announcements

Update - Notification of buy-back - TOP

Daily Share Buy-Back Notice

  • Nov 8, 2024
  • 6 pages

Update - Notification of buy-back - TOP

Daily Share Buy-Back Notice

  • Nov 7, 2024
  • 6 pages

Update - Notification of buy-back - TOP

Daily Share Buy-Back Notice

  • Nov 5, 2024
  • 6 pages

Change in substantial holding from Thorney Holdings Pty Ltd

Change in substantial holding

  • Nov 1, 2024
  • 5 pages

Change in substantial holding for EPY

Change in substantial holding

  • Nov 1, 2024
  • 4 pages

View all TOP announcements

August 2023

Rich Lister Alex Waislitz resets his hurdles every year.

Fees never falter at Alex Waislitz’s Thorney Opportunities

The fund resets its previous performance every financial year, investors charged when the fund grows even if it’s still smaller than it was before.

  • Myriam Robin

September 2022

While ETFs are all the rage and growing by billions of dollars, listed investment companies (LICs) are like the forgotten old-timers of the ASX.

Bargain-hunting opportunities for the brave

Taking a punt on the underlying assets of some listed investment companies is a strategy that could pay off, but there are risks in premium and discount distortions.

  • Emma Rapaport

June 2022

Willed co-founders Tim Glasson, Aaron Zelman and David Kaplan are creating a death management platform.

Killer investors inject $6m into death tech start-up

Willed has scored $6 million from institutional investors including Thorney Investment Group and Ellerston Capital to expand its ‘death management platform.’

  • Yolanda Redrup

June 2021

Alex Waislitz’s Thorney Opportunities LIC’s performance fee accrual gets reset each financial year.

Thorney’s questionable performance fees

The asset manager’s LICs won’t account for negative returns in a prior financial year when calculating performance fees owed in a current financial year.

  • Tom Richardson

September 2020

Rich Lister Alex Waislitz.

OneVue takeover bid turns very Thorney

Have you heard the one about comparing a low-margin unit registry business to fast-growing platform provider Netwealth?

  • Tom Richardson
Advertisement

July 2020

Rich Lister Alex Waislitz is trying to pick winning stocks while locked down in Melbourne.

How this Rich Lister is backing the tech boom

Alex Waislitz is navigating what he says is the most challenging and unpredictable period in his 30-year investment career and has defended the performance of his listed investment vehicles Thorney Opportunities and Thorney Technologies.

  • Julie-anne Sprague

June 2020

Thorney Investments chairman Alex Waislitz was a pre-IPO investor in Mesoblast.

Mesoblast re-enters ASX 200 after wild two decade ride

Investors are split whether the stem cell company is a blue-chip of tomorrow or a cash drain.

  • Carrie LaFrenz and Tom Richardson
Melbourne billionaire Alex Waislitz has upped his stake in OneVue.

The Thorn(ey) in Iress' side gets bigger

Financial markets software company Iress Ltd's quest to take out ASX-listed OneVue just got a couple of percentage points harder. 

  • Sarah Thompson, Anthony Macdonald and Tim Boyd

July 2019

Alex Waislitz believes ACM will deliver for his shareholders over time.

Waislitz and Catalano's ACM investment unveiled

Alex Waislitz's public and private investment firms have invested in ACM and Antony Catalano will hold half of the regional publishing business.

  • Max Mason

September 2018

About 20,000 West Coast Eagles fans are expected to descend on Melbourne this week.

Rich Listers jet in for AFL grand final

Rich Listers are jetting in for the AFL grand final, with expectations for a massive crowd likely to help set an AFL finals attendance record.

  • Updated
  • Julie-anne Sprague

June 2018

Calix targets ASX listing, Thorney among early stage investors

Big name investors like the smell of the company behind technology that stops sewers stinking and may eventually extend the battery power of a Tesla car.

  • Updated
  • Sarah Thompson, Anthony Macdonald and Julie-anne Sprague

May 2018

2018 AFR Rich List: Billionaire investor Alex Waislitz planning big property move

Billionaire investor Alex Waislitz has mostly made his money in ASX-listed small and mid-cap stocks, but he wants to focus more on property.

  • Updated
  • John Stensholt

April 2018

A mineral sands mine in WA is the latest beneficiary of the federal government's Northern Australia Infrastructure Fund.

MDL investors seek higher bid from French suitor

Some of Australia's best known investors will seek a higher price from French giant Eramet before they part with all of their shares in takeover target Mineral Deposits (MDL).

  • Updated
  • Peter Ker

November 2017

After a big year Alex Waislitz's next tip is to get into mining services stocks

It has been a bumper year for billionaire investor Alex Waislitz, with much of his success based on a handful of stocks.

  • Updated
  • John Stensholt

Thorney Opportunities in a halt, seeks equity injection

Alex Waislitz's Thorney Opportunities is seeking to raise $18.3 million in a placement of new shares on Tuesday.

  • Updated
  • Sarah Thompson, Anthony Macdonald and Joyce Moullakis
Advertisement

August 2017

How the Rich Invest: Alex Waislitz owns the hottest tech stock on the ASX

Alex Waislitz's Thorney Technologies has had a good start as a listed investment company, thanks to its big holding in Perth firm Updater.

  • Updated
  • John Stensholt

January 2017

Alex Waislitz says M&A activity to ramp up in 2017

Thorney Opportunities has doubled revenue and profit in the first half of 2017 financial year.

  • Updated
  • John Stensholt

Rich Listers backing Alex Waislitz's Thorney Technologies

Costa, Besen, Tertini – Alex Waislitz's Thorney Technologies, which lists on Wednesday, has captured plenty of rich backers.

  • Updated
  • John Stensholt

How the Rich Invest: Tasmania's Dale Elphinstone on stock picking

Several stocks Dale Elphinstone owns have doubled in value in 12 months.

  • Updated
  • John Stensholt

June 2016

Mesoblast dives 42pc after partner Teva withdraws from heart failure trials

Mesoblast chief executive Silviu Itescu says criticism of the stem cell therapy developer's commercialisation strategy is misplaced.

  • Updated
  • Jessica Gardner and James Thomson

Original URL: https://www.afr.com/company/top-1j7